As is reported, the level of IL-1β (inflammasome product) increased at 1 day after AIS (HC: 6,064.85 ± 1,735.25; AIS patients: 1,1345.56 ± 1,5130.49, P < 0.05) (Figure 1A). The gene discussed is IL1B; the disease is androgen insensitivity syndrome.